학술논문
Single Institution Experience with Nivolumab in Treatment of Patients with Relapsed or Refractory Hodgkin’s Lymphoma
Document Type
Abstract
Author
Source
In Clinical Lymphoma Myeloma and Leukemia September 2017 17 Supplement 2:S323-S324
Subject
Language
ISSN
2152-2650